|Articles|July 1, 2018
- Pharmaceutical Executive-07-01-2018
- Volume 38
- Issue 7
Pharmaceutical Executive, July 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Opioid Litigation: Evading the Widening Crosshairsalmost 8 years ago
Patient & Customer-Centric Commercializationalmost 8 years ago
Compliance: The Critical Cog in Pharma Machinealmost 8 years ago
Gaining Ground with Stem Cells: Gil Van Bokkelen, Athersysalmost 8 years ago
A Seat at the Strategy Tablealmost 8 years ago
Regulatory Innovation Generates Breakthroughsalmost 8 years ago
China’s Biopharma Rise: Opportunities and ThreatsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
4
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
5